On 9 July at 10:30 am EDT/4:30 pm CET, experts will recap the latest data from EHA 2024, speculate on how it may fit into treatment guidelines, and consider how best to incorporate recent advances into the treatment algorithm. They will discuss the key factors to consider when selecting a therapy for a patient and how to ensure that it is a shared decision with the patient.
LC worked in collaboration with Medscape Global Oncology to develop this program. It is important that health providers to engage their patients and are equipped to have appropriate conversations with their patients about the targeted therapies for R/R CLL that are available.
The webinar is intended for hematology/oncology specialists and other members of the oncology multidisciplinary team.
